Clinical trial

Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)

NCT01035528

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record insulin glargine Normalized identity: insulin glargineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record metformin Normalized identity: metforminView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2005-04-01

PhasePHASE4

Conditions

Coronary Artery Diseaseverified · MONDO: coronary artery disorder

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

insulin glargineDRUG · verified · RxNorm: insulin glargine

metforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Munich Municipal Hospitallead sponsor

Aventis Pharmaceuticalscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01035528 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.